Accelerating the Development of More Effective & Precise Oncology Therapies to Targeted Patient Populations

Developing safer and more effective targeted therapeutics for specific cancer indications remains a huge unmet medical need. Therefore, gaining access to the latest scientific advancements, novel targets and benchmarking clinical progress to demonstrate safety and efficacy remains critical.

For over a decade we’ve worked closely with biopharma to provide valuable insights and meaningful connections to understand novel therapeutic modalities, enhance clinical trial design, and minimize on/off target toxicities to improve safety and predict positive patient responders.

From industry-defining conferences, clinical trials database to tailored market research and expert networks, we provide meaningful insights to accelerate the development of your precision oncology pipeline to targeted patient populations.


Get in touch

We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.

Standard Form - Precision Oncology

"*" indicates required fields

Fill out the form below with your question and one of our team will get back to you.